Polyunsaturated fatty acids and type 2 diabetes: Impact on the glycemic control mechanism

References

• ADA. (2014). American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 37:S14–S80.
   PubMed Web of Science ®Google Scholar
• Belchior, T. et al. (2015). Omega-3 fatty acids protect from diet-induced obesity, glucose intolerance, and adipose tissue inflammation through PPARγ-dependent and PPARγ-independent actions. Mol. Nutr. Food Res. 59(5):957–967.
   PubMed Web of Science ®Google Scholar
• Berger, M. M. et al. (2013). Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: A randomized controlled trial. Am. J. Clin. Nutr. 97(2):246–254.
   PubMed Web of Science ®Google Scholar
• Briscoe, C. P. et al. (2003). The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278(13):11303–11311.
   PubMed Web of Science ®Google Scholar
• Chen, H. et al. (2005). Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes. 54(7):1914–1925. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15983190
   PubMed Web of Science ®Google Scholar
• Dasu, M. R. et al. (2010). Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 33(4):861–868.
   PubMed Web of Science ®Google Scholar
• El-Sayed, M.-I. K. (2011). Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J. Ethnopharmacol. 137(1):643–651.
   PubMed Web of Science ®Google Scholar
• Evans, J. L. et al. (2005). Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: Simultaneous activation of PPAR alpha, PPAR gamma, and PPAR delta. Curr. Diab. Rev. 1(3):299–307.
   PubMedGoogle Scholar
• Gannon, N. P. et al. (2015). Dietary stimulators of GLUT4 expression and translocation in skeletal muscle: A mini-review. Mol. Nutr. Food Res. 59(1):48–64.
   PubMed Web of Science ®Google Scholar
• Gaster, M. et al. (2001). GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: Is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes. 50(6):1324–1329.
   PubMed Web of Science ®Google Scholar
• Hirasawa, A. et al. (2005). Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11(1):90–94.
   PubMed Web of Science ®Google Scholar
• Huebschmann, A. G. et al. (2006). Diabetes and advanced glycoxidation end products. Diabetes Care. 29(6):1420–1432.
   PubMed Web of Science ®Google Scholar
• Itoh, Y. et al. (2003). Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40. Nature. 422(6928):173–176.
   PubMed Web of Science ®Google Scholar
• Kampmann, U. et al. (2011). GLUT4 and UBC9 protein expression is reduced in muscle from type 2 diabetic patients with severe insulin resistance. PLoS ONE. 6(11):1–7.
   Web of Science ®Google Scholar
• Katz, A. et al. (2000). Quantitative insuln sensitivity check index: A simple, accurate methof for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 85(7):2402–2410.
   PubMed Web of Science ®Google Scholar
• Kawai, T. and Akira, S. (2006). TLR signaling. Cell. Death Differ. 13(5):816–825.
   PubMed Web of Science ®Google Scholar
• Kondo, K. et al. (2014). A fish-based diet intervention improves endothelial function in postmenopausal women with type 2 diabetes mellitus: A randomized crossover trial. Metabolism. 63(7):930–940.
   PubMed Web of Science ®Google Scholar
• Lamping, K. et al. (2013). Modification of high saturated fat diet with n‐3 polyunsaturated fat improves glucose intolerance and vascular dysfunction. Diab. Obes. Metab. 15(2):144–152.
   PubMed Web of Science ®Google Scholar
• Lee, J. Y. (2003). Differential modulation of Toll-like receptors by fatty acids: Preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 44(3):479–486.
   PubMed Web of Science ®Google Scholar
• Lesná, I. et al. (2013). Effect of different types of dietary fatty acids on subclinical inflammation in humans. Physiol. Res. 62:145–152.
   PubMed Web of Science ®Google Scholar
• Li, D. (2015). Omega-3 polyunsaturated fatty acids and non-communicable diseases: Meta-analysis based systematic review. Asia Pac. J. Clin. Nutr. 24(1):10–15.
   PubMed Web of Science ®Google Scholar
• Li, S. et al. (2011). Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism Clin. Exp. 60(4):474–479.
   PubMed Web of Science ®Google Scholar
• Matravadia, S. et al. (2014). Both linoleic and -linolenic acid prevent insulin resistance but have divergent impacts on skeletal muscle mitochondrial bioenergetics in obese Zucker rats. AJP Endocrinol. Metabol. 307(1):E102–E114.
   PubMed Web of Science ®Google Scholar
• Matthews, D. R. et al. (1985). Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7):412–419.
   PubMed Web of Science ®Google Scholar
• Miller, E. R. et al. (2013). The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: Results of the GO-FISH trial. Diabetes Care. 36(November):1462–1469.
   PubMedGoogle Scholar
• Moller, D. E. and Berger, J. P. (2003). Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation. Int. J. Obes. Rel. Metab. Disord. 27(Suppl 3):S17–S21.
   PubMed Web of Science ®Google Scholar
• Müllner, E. et al. (2014). Impact of polyunsaturated vegetable oils on adiponectin levels, glycaemia and blood lipids in individuals with type 2 diabetes: A randomised, double-blind intervention study. J. Hum. Nutr. Diet. 27(5):468–478.
   PubMed Web of Science ®Google Scholar
• Nardi, F. et al. (2014). Enhanced insulin sensitivity associated with provision of mono and polyunsaturated fatty acids in skeletal muscle cells involves counter modulation of PP2A. Plos One. 9(3):1–10.
   Web of Science ®Google Scholar
• Neto, B. G. and Tambascia, M. A. (2002). Avaliação laboratorial e diagnóstico da resistencia insulínica. Atherosclerosis. 13(2):42–49.
   Google Scholar
• Ogawa, S. et al. (2013). Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetes. Tohoku J. Exp. Med. 231:63–74.
   PubMed Web of Science ®Google Scholar
• Oh, D. Y. et al. (2010). GPR120 Is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 142(5):687–698.
   PubMed Web of Science ®Google Scholar
• Olefsky, J. et al. (1973). Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes. 22(7):507–513.
   PubMed Web of Science ®Google Scholar
• Oliveira, E. P. et al. (2005). Índice HOMA (homeostasis model assessment) na prática clínica: Uma revisão. Bras. Patol. Med. Lab. 41(4):237–243.
   Google Scholar
• Ottum, M. S. and Mistry, A. M. (2015). Advanced glycation end-products: Modifiable environmental factors profoundly mediate insulin resistance. J. Clin. Bioch. Nutr. 56(3):166–170.
   PubMed Web of Science ®Google Scholar
• Sarbolouki, S. et al. (2013). Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: A double-blind randomised clinical trial. Singapore Med. J. 54(07):387–390.
   PubMed Web of Science ®Google Scholar
• Schenk, S., Saberi, M. et al. (2008). Insulin sensitivity: Modulation by nutrients and inflammation. J. Clin. Invest. 118(9):2992–3002.
   PubMed Web of Science ®Google Scholar
• Shoelson, S. E. et al. (2006). Inflammation and insulin resistance. J. Clin. Invest. 116(7):1793–1801.
   PubMed Web of Science ®Google Scholar
• St-Onge, M. et al. (2007). Snack chips fried in corn oil alleviate cardiovascular disease risk factors when substituted for low-fat or high-fat snacks. Am. J. Clin. Nutr. 85(6):1503–1510.
   PubMed Web of Science ®Google Scholar
• Uribarri, J. et al. (2010). Advanced Glycation end products in foods and a practical guide to their reduction on the diet. J. Am. Diet Assoc. 110(6):911–916.
   PubMedGoogle Scholar
• Van Dieren, S. et al. (2010). The global burden of diabetes and its complications: An emerging pandemic. Eur. J. Cardiovasc. Prev. Rehabil. 17:S3–S8.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2003). Diet, Nutrition and the Prevention of Chronic Diseases, No. 916; i–viii & 1–149 backcover. WHO, Geneva, Switzerland.
   Google Scholar
• Wild, S. et al. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diab. Care. 27(5):1047–1053.
   PubMed Web of Science ®Google Scholar
• Wong, S. W. et al. (2009). Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 284(40):27384–27392.
   PubMed Web of Science ®Google Scholar
• Wu, J. H. et al. (2012). Omega-3 fatty acids and incident type 2 diabetes: A systematic review and meta-analysis. Brazilian J. Nutr. 107(2):S214–S227.
   Google Scholar
• Zhao, G. et al. (2004). Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J. Nutr. 134(11):2991–2997.
   PubMed Web of Science ®Google Scholar